Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia

Neurocognitive deficits are a core feature of schizophrenia and, therefore, represent potentially critical outcome variables for assessing antipsychotic treatment response. We performed genome-wide association studies (GWAS) with 492K single nucleotide polymorphisms (SNPs) in a sample of 738 patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McClay, Joseph L, Adkins, Daniel E, Åberg, Karolina, Bukszár, Jozsef, Khachane, Amit N, Keefe, Richard S E, Perkins, Diana O, McEvoy, Joseph P, Stroup, T Scott, Vann, Robert E, Beardsley, Patrick M, Lieberman, Jeffrey A, Sullivan, Patrick F, van den Oord, Edwin J C G
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3055694/
https://ncbi.nlm.nih.gov/pubmed/21107309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2010.193
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados